Coverage dated September 25, 2026 to October 2, 2026

FDA panel endorses first-of-its-kind cancer blood test

Headline from WPRI Providence

Federal health advisers on Wednesday endorsed a blood test designed to spot signs of various cancers in apparently healthy people while warning that it's far from clear how well the technology works.

WPRI Providence's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

2 articles, oldest first.

  1. WPRI Providence

    FDA panel endorses first-of-its-kind cancer blood test (opens WPRI Providence)

    Published

    WPRI Providence's feed description

    Federal health advisers on Wednesday endorsed a blood test designed to spot signs of various cancers in apparently healthy people while warning that it's far from clear how well the technology works.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

FDA panel endorses first-of-its-kind cancer blood test | Since Then